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ABSTRACT
Intracellular amyloid-β (Aβ) accumulation is a key feature of early
Alzheimer’sdiseaseandprecedestheappearanceofAβ inextracellular
plaques. Aβ is generated through proteolytic processing of amyloid
precursor protein (APP), but the intracellular site of Aβ production is
unclear. APP has been localized to multivesicular bodies (MVBs)
where sorting of APP onto intraluminal vesicles (ILVs) could promote
amyloidogenic processing, or reduceAβ production or accumulation by
sorting APP and processing products to lysosomes for degradation.
Here, we show that APP localizes to the ILVs of a subset of MVBs that
also traffic EGF receptor (EGFR), and that it is delivered to lysosomes
for degradation. Depletion of the endosomal sorting complexes
required for transport (ESCRT) components, Hrs (also known as
Hgs) or Tsg101, inhibited targeting of APP to ILVs and the subsequent
delivery to lysosomes, and led to increased intracellular Aβ
accumulation. This was accompanied by dramatically decreased Aβ
secretion. Thus, the early ESCRT machinery has a dual role in limiting
intracellular Aβ accumulation through targeting of APP and processing
products to the lysosome for degradation, and promoting Aβ secretion.
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INTRODUCTION
Alzheimer’s disease is characterized by progressive loss of memory
and cognitive function, and histologically characterized by neuronal
loss, extracellular amyloid plaques, dystrophic neurites and
neurofibrillary tangles of hyperphosphorylated Tau (Glenner,
1989; Goedert et al., 1988; Selkoe et al., 1986). Plaques are
extracellular aggregates of Aβ peptides (Glenner and Wong, 1984)
generated by sequential proteolysis of APP by β-site APP cleaving
enzyme 1 (BACE1) and the γ-secretase complex. APP can
alternatively be processed by α-secretase, which cleaves within
the Aβ sequence, precluding Aβ formation.
Both the trans-Golgi network (TGN) and the endolysosomal
pathway contain APP, BACE1 and γ-secretase, and are proposed
sites of Aβ generation. Newly synthesized APP can traffic from the
TGN to endosomes either directly through binding to the adaptor
AP-4 (Burgos et al., 2010) or via the plasma membrane, and can
also undergo retromer-dependent recycling to the TGN (Vieira
et al., 2010). APP and its processing products have been localized to
multivesicular bodies (MVBs) in Alzheimer’s disease brains
(Takahashi et al., 2004, 2002) and cultured neurons (Morel et al.,
2013). MVBs have a number of fates including fusion with the
lysosome, fusion with the cell surface for the release of intraluminal
vesicles (ILVs) as exosomes, fusion with autophagosomes to
generate amphisomes and the biogenesis of lysosome-related
organelles such as melanosomes. In pigmented cells PMEL is
targeted to ILVs where it undergoes proteolytic processing to
generate amyloid striations upon which melanin is deposited
(Berson et al., 2001).
Several populations of MVBs exist (White et al., 2006) and ILVs
can be formed by different mechanisms (Edgar et al., 2014; Stuffers
et al., 2009; Subra et al., 2007; Trajkovic et al., 2008; Wollert and
Hurley, 2010). The endosomal sorting complexes required for
transport (ESCRT) machinery, which is composed of four
complexes (0–III), binds ubiquitylated cargo and generates ILVs that
are delivered to lysosomes and degraded. APP can be ubiquitylated
(Watanabe et al., 2012) in a manner that promotes its targeting to ILVs
(Morel et al., 2013). Interfering with the potential interaction between
early ESCRT components and APP has been reported to both increase
(Morel et al., 2013) and decrease (Choy et al., 2012) Aβ secretion.
Depleting later ESCRT components promotes APP traffic to the TGN
and increased Aβ secretion (Choy et al., 2012). Intriguingly PMEL
sorting onto ILVs is essential for its amyloidogenic processing but
occurs independently of ESCRTs (Theos et al., 2006). The extent to
which ESCRT-dependent targeting of APP to ILVs might play a
similar positive role in Aβ production, or might reduce Aβ production
by targeting APP to the lysosome and/or removing APP from the
recycling pathway to the TGN, remains unclear.
Studies of the role of the ESCRT machinery in regulating APP
traffic and Aβ production have been performed in a variety of
cultured cell lines and primary neurons, in which intracellular Aβ is
difficult to detect. Most studies have therefore analysed ESCRT
roles in Aβ secretion, rather than intracellular accumulation. The
importance of intracellular versus extracellular Aβ is a subject of
considerable debate. Transgenic mice display intraneuronal Aβ at
the same age as initial pathological manifestations and synaptic
dysfunction, which is prior to the appearance of extracellular
plaques (Oddo et al., 2003). In this study, we investigate the role of
ESCRT-mediated sorting within MVBs in intracellular Aβ
accumulation. We reveal a role for early ESCRT components in
limiting intracellular Aβ accumulation by both promoting lysosomal
targeting and promoting Aβ secretion.
RESULTS
APP is localized to the Golgi and ILVs of a subpopulation of
MVBs in H4-APP cells
Immunofluorescent staining of H4 neuroglioma cells stably
expressing human APP (H4-APP) with the antibody 6E10, which
labels both APP and Aβ (hereafter anti-APP/Aβ antibody), revealedReceived 18 February 2015; Accepted 21 May 2015
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that there was a perinuclear pool that colocalized with the Golgi
marker TGN46 (also known as TGOLN2), plus punctate staining,
typical of endosomes and lysosomes (Fig. 1A). As no marker
accurately distinguishes between MVBs and lysosomes, electron
microscopy was used to determine the identity of the punctate
staining. We previously showed that electron lucence, a diameter
>200 nm, and one or more discrete ILVs in a single section plane
defines MVBs that are functionally distinct from lysosomes, as they
lack the capacity to degrade endocytosed EGF (Futter et al., 1996;
Wherlock et al., 2004). Lysosomes are electron dense, can contain
ILVs but also contain membrane whorls and can degrade
endocytosed EGF (Futter et al., 1996; Wherlock et al., 2004).
Immunoelectron microscopy showed that the majority of 6E10
staining was confined to the Golgi and MVBs, where most was on
ILVs but some was on the limiting membrane (Fig. 1B). Analysis of
the 6E10 gold distribution onMVBs revealed the labelling not to be
randomly distributed but, rather, that it was confined to a subset
(39%) of MVBs and that a second population of 6E10-negative
MVBs existed (Fig. 1C). 6E10 staining was found on MVBs both
sparsely and densely packed with ILVs, and so did not correlatewith
MVBmaturation state. Lysosomes were not stained. 6E10 binds the
first 16 residues of Aβ and thus detects full-length APP (fl-APP),
the β C-terminal fragment (β-CTF) and Aβ. Similar results were
obtained using another pan-Aβ antibody, 4G8 (data not shown).
Several Aβ-specific antibodies tested on cell lines overexpressing
APP showed no specific staining.
Western blotting H4-APP lysates using the 6E10 antibody
showed the predominant species to be fl-APPwith much less intense
bands corresponding to the size of CTFs and little or no Aβ
(Fig. 1D). These data suggest that, like many non-neuronal and
neuronal cell lines, H4-APP cells produce very little Aβ and that
the majority of the 6E10 signal detected by immunofluorescence
and immunoelectron microscopy is likely to represent fl-APP.
Consistent with this, treatment of H4-APP cells with the γ-secretase
inhibitor DAPT, to prevent Aβ generation, caused no detectable
change in 6E10 staining as assessed by immunoelectronmicroscopy
(supplementary material Fig. S1A,B), and an antibody against the
N-terminus of APP, which does not stain β-CTF or Aβ, showed the
same dual localization to the Golgi and the ILVs of MVBs as 6E10
(supplementary material Fig. S1C,D).
To determinewhether Aβ could be detected in a subset of MVBs in
neurons, hippocampus from age-matched wild-type and Tg2576
mice, which overexpress Swedish mutant APP (sweAPP) and present
detectable levels of intraneuronal deposits of Aβ (Takahashi et al.,
2002), were stained with anti-Aβ antibodies and assessed by
immunoelectron microscopy. 6E10 and Aβ40-specific antibodies
localized to the ILVs of a subset ofMVBs in the Tg2576mice (Fig. 2).
APP traffics through EGFR-positive endosomes to lysosomes
and is degraded
We have previously shown that EGFR traffics in a subpopulation of
MVBs destined for the lysosome (White et al., 2006). To determine
whether APP is trafficked in the same MVBs, cells were incubated
with EGF-488 for 10 and 45 min when EGF–EGFR complexes are
primarily localized to early endosomes and MVBs, respectively
(Futter et al., 1996). Fig. 3A shows that a small proportion of
punctate 6E10 staining colocalized with EGF after 10 min,
suggesting that only a small proportion of 6E10-positive puncta
are early endosomes (14% APP colocalized with EGF, Fig. 3B).
However, after 45 min stimulation, the majority of 6E10-positive
puncta contained EGF (37% of the total APP colocalized with EGF,
the majority of the remainder was in the TGN). These data show that
APP is trafficked in the same population of MVBs that deliver
EGFR to the lysosome for degradation. Although in control cells,
we did not detect APP in lysosomes (Fig. 1), treatment of H4-APP
cells with the protease inhibitor leupeptin caused a time-dependent
increase in the amount of APP within cathepsin-D-positive
compartments (Fig. 3C,D). This indicates that APP can be
Fig. 1. APP localizes to the Golgi and ILVs of a subpopulation of MVBs. (A) Untransfected H4-UnT and H4-APP cells were stained for APP/Aβ (6E10; green),
TGN46 (magenta) and DAPI (blue). Scale bar: 10 μm. (B) In ultrathin cryosections of H4-APP cells, 6E10 immunogold labelling is on a subset of MVBs (asterisks)
and the Golgi, although some MVBs lack label (arrows). Scale bars: 100 nm. (C) Counting 6E10 gold particles per MVB (n=120) shows populations of 6E10
negative and positive MVBs (approximately four particles per MVB). (D) H4-UnT and H4-APP cells were western blotted with 6E10.
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trafficked to the lysosome but is rapidly degraded and only
detectable following inhibition of lysosomal degradation.
Depletion of Hrs inhibits traffic of APP to ILVs
Targeting of EGFR to the ILVs of MVBs depends on EGFR-
ubiquitylation-dependent engagement of the ESCRT machinery.
To measure potential ubiquitylation of APP N2a-UnT and N2a-APP
cells were transfected with ubiquitin–Myc and lysates were
immunoprecipitated with 6E10. Blotting of the immunoprecipitations
with anti-Myc antibody revealed that fl-APP can be ubiquitylated
(supplementary material Fig. S2A) and there are several potential sites
of APP ubiquitylation (supplementary material Fig. S2B). Depletion
of the ESCRT0 component Hrs (also known as Hgs), which
binds ubiquitylated cargo, caused APP to redistribute from ILVs to
the limiting membrane of enlarged endosomes, as shown by
immunoelectron microscopy (Fig. 4A), such that 31.5% of 6E10
gold particles localized to the limiting membrane in control cells
increasing to 73.6% in Hrs-depleted cells. Immunofluorescence
analysis showed that the 6E10-positive punctae were clearly enlarged
in Hrs-depleted cells (Fig. 4B) and sometimes 6E10-positive ‘rings’
could be observed, as previously described (Choy et al., 2012). Some
Hrs-depleted MVBs contained a population of unusually small ILVs,
only detectable on glutaraldehyde-fixed specimens (Fig. 4A), as shown
in our recent study on Hrs-depleted HeLa cells (Edgar et al., 2014).
Hrs and Tsg101 depletion reduce lysosomal delivery of APP
In order to determine whether depleting ESCRT components
affected delivery of APP to lysosomes, we analysed the
colocalization of APP with LAMP1. A change in the amount of
co-staining of APP with LAMP1 upon ESCRT depletion could be
caused by a change in the distribution of LAMP1 or by a change in
the efficiency of delivery of APP to the lysosome. These two
possibilities can be distinguished by incubation of the cells with
leupeptin to inhibit lysosomal enzyme activity. This would be
expected to have no effect on the distribution of LAMP1 but, as
shown in Fig. 3, it increased APP signal in lysosomes by inhibiting
degradation. Without leupeptin there was limited co-staining of
APP with LAMP1 in control cells and cells treated with small
interfering RNA (siRNA) against Hrs (siHrs) (∼8 and 9%,
respectively) (Fig. 5A,B). With leupeptin there was a 2-fold
increase in APP co-staining with LAMP1 in control cells compared
with only a 1.5-fold increase in siHrs-treated cells (Fig. 5A,C),
indicating inhibition of lysosomal delivery of APP in Hrs-depleted
cells. Although cells treated with siRNA against Tsg101 (siTsg101)
displayed higher APP and LAMP1 colocalization in controls, there
was only a 1.25-fold increase following leupeptin treatment,
indicating a greater inhibition of APP delivery to lysosomes in
siTsg101-treated cells (Fig. 5A,C).
Hrs or Tsg101 depletion reduces Aβ40 secretion but
increases intracellular APP and Aβ
The effects of ESCRT depletion on Aβ accumulation and secretion
was tested on N2a-APP cells, which secrete more Aβ than H4-APP
cells and show a similar redistribution of APP to the perimeter
membrane of enlarged MVBs, frequently visible as ‘rings’, upon Hrs
or Tsg101 depletion (supplementary material Fig. S3). Depletion of
Fig. 2. APP and Aβ localizes to the ILVs of a subpopulation of MVBs in hippocampus of Tg2576 mice. Ultrathin sections of hippocampus of Tg2576 mice
were stained with the anti-APP/Aβ antibody 6E10 (A) or Aβ40-specific antibody G2-10 (B). Arrows show MVBs negative of gold labelling. Scale bars: 200 nm.
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Hrs orTsg101 led to a 73%and80% reduction in secretedAβ40 levels
respectively, as measured by ELISA of media samples (Fig. 6A),
without any corresponding decrease in release of the intracellular
enzyme lactate dehydrogenase (LDH) (Fig. 6B). Secreted Aβ levels
do not necessarily reflect intracellular Aβ levels and so intracellular
and secreted Aβ were analysed by western blotting, which, though
challenging, allows distinction between fl-APP and processing
products (Gouras et al., 2012). Western blotting of medium from
N2a-APP cells showed reduced secreted Aβ levels following Hrs or
Tsg101 depletion (Fig. 6C,D), in agreement with the ELISA results.
Western blotting of cell lysates showed an increase inAPP levels upon
Hrs or Tsg101 depletion consistent with reduced delivery of APP to
the lysosome (Fig. 6E,F). Interestingly, although α- and β-CTF levels
were unchanged by Hrs or Tsg101 depletion (Fig. 6E), the
intracellular levels of Aβ were dramatically increased following Hrs
depletion (Fig. 6E,G). It is not possible to directly measure the effects
of ESCRT depletion on Aβ generation, as the intracellular Aβ levels
are a balance between production, degradation and secretion.
However the intracellular Aβ accumulation that accompanied
reduced Aβ secretion upon Hrs depletion suggests that Hrs-
dependent targeting of APP to ILVs is not necessary for Aβ
production but that Hrs and Tsg101 are involved in Aβ secretion.
Fig. 3. APP traffics through the same MVBs as EGFR. (A) H4-APP cells stimulated with EGF–Alexa-Fluor-488 (EGF-488; green) for 10 or 45 min were
stained for APP/Aβwith 6E10 (red). Scale bar: 5 μm. (B) Quantification of APP colocalization with EGF-488. (C) H4-APP cells treated with leupeptin were stained
with 6E10 (green), cathepsin D (red) and DAPI (blue). Scale bars: 10 μm. (D) Quantification of 6E10 colocalization with cathepsin D. All results are mean±s.d.
(n=3 separate experiments). *P<0.05, ***P<0.005 (Student’s t-test).
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Despite the clinical importance of Aβ, the role of the endocytic
pathway versus the TGN and the role of sorting within MVBs in
regulating the intracellular accumulation and secretion of Aβ remain
unclear. In keeping with previous studies, we found that APP
localized predominantly to endosomes and the TGN, and now show
that, within the endocytic pathway, APP is found mainly on the
ILVs of a subset of MVBs. Sorting of APP onto ILVs could promote
Aβ production by providing favourable conditions for
amyloidogenic processing, as it does for PMEL in melanogenic
cells. Consistent with this hypothesis, we found Aβ40 on the ILVs
of MVBs in mouse brain from Tg2576 mice. Alternatively sorting
of APP to ILVs could prevent intracellular Aβ accumulation by
targeting APP and/or its processing products for lysosomal
degradation. Consistent with this hypothesis, we found APP in
EGFR-containing MVBs, an MVB subpopulation that normally
fuses with lysosomes, and lysosomal accumulation of APP in cells
treated with protease inhibitor.
To determine whether sorting of APP onto ILVs has a positive or
negative effect on Aβ accumulation, we aimed to inhibit the ILV
sorting machinery and analyse the effects on intracellular Aβ levels.
EGFR is targeted to the ILVs of MVBs by ubiquitylation-dependent
interaction with the ESCRT machinery. In contrast, PMEL, which
depends on sorting to ILVs for amyloidogenic processing, is
targeted to ILVs independently of ubiquitylation and the ESCRT
machinery (Theos et al., 2006; van Niel et al., 2011). That APP
traffics predominantly in the same MVBs that traffic EGFR implied
that the ESCRT machinery was involved in APP sorting. However,
ESCRT-dependent and -independent ILV sorting mechanisms are
not entirely segregated within separate populations of MVBs. van
Niel et al. (van Niel et al., 2011) have shown that the C-terminal
fragment of PMEL that remains after amyloidogenic processing is
targeted to the lysosome in an ESCRT-dependent manner and we
have recently shown that Hrs-dependent and Hrs-independent ILVs
can form in the same MVB (Edgar et al., 2014).
Several studies, including our own, show that APP can be
ubiquitylated (Morel et al., 2013; Watanabe et al., 2012) and, hence,
could potentially engage the ESCRT machinery. A previous study
has shown that depletion of the ESCRT0 component Hrs or the
ESCRTI component Tsg101 leads to the retention of APP in early
endosomes at the expense of the TGN (Choy et al., 2012) and
proposed a role for Hrs and Tsg101 in retromeric traffic of APP to
the TGN. Another recent study presented evidence for a role for the
ESCRT machinery in sorting APP to ILVs. Expression of a poorly
ubiquitylated mutant APP or depletion of the phosphoinositide 3-
kinase (PI3K) Vps34 and its effector Hrs inhibits sorting of APP to
ILVs (Morel et al., 2013). Here, we show that depletion of Hrs or
Tsg101 inhibit sorting of APP to ILVs of a subset of MVBs, directly
demonstrating a role for the ESCRT machinery in sorting APP to
ILVs.
Thus, two amyloidogenic proteins, PMEL and APP, are sorted
onto ILVs by different mechanisms. ESCRT-independent sorting
of PMEL to ILVs promotes amyloidogenic processing. Does
sorting of APP onto ILVs, serve a similar purpose, albeit utilizing a
different machinery, or does ESCRT-dependent ILV sorting target
APP and its processing products to the lysosome and, thereby,
reduce Aβ accumulation? Consistent with the latter possibility, we
found that Hrs or Tsg101 depletion increased cellular APP levels
and inhibited APP delivery to the lysosome. Morel et al. proposed
that ESCRT-mediated ILV targeting limits Aβ production after
finding that silencing Vps34, or expressing ubiquitylation-deficient
APP, increased Aβ secretion (Morel et al., 2013). However, here,
we found that Hrs or Tsg101 depletion reduced Aβ secretion. Choy
et al. also found reduced Aβ secretion on Hrs or Tsg101 depletion
but found increased Aβ secretion on depletion of the later ESCRT
components CHMP and Vps34 (Choy et al., 2012). This enhanced
Fig. 4. Redistribution of APP from ILVs to the limiting membrane of MVBs
after Hrs depletion. (A) Cryosections of H4-APP and Hrs-depleted H4-APP
cells (siHrs) were stained for APP/Aβ with 6E10 (upper two panels, cells fixed
with 4% PFA; lower panel, cells fixed with 4% PFA and 0.2% glutaraldehyde).
Scale bars: 200 nm. (B) Confocal microscopy reveals 6E10-positive
endosomal rings following Hrs depletion (arrows). Scale bars: 5 μm.
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Aβ secretion required retromer-dependent redistribution of APP to
the TGN and these authors concluded that the TGN was the
major site of Aβ production. How can treatments likely to reduce
ESCRT-dependent sorting of APP to ILVs enhance Aβ secretion in
one study (Morel et al., 2013) and reduce them in others (Choy
et al., 2012) (and the current study)? Although differences in cell
types might underlie these apparent differences (HEK293 cells in
Choy et al. and Hela cells in Morel et al.), we can add a key
component that was absent from previous studies. As well as Aβ
secretion, we measured intracellular Aβ levels. Although depletion
of Hrs inhibited Aβ secretion, intracellular Aβ levels were
considerably increased. Although we cannot eliminate the
possibility that Hrs depletion affects Aβ production, the elevated
intracellular Aβ levels imply that Hrs-dependent sorting to ILVs
does not promote Aβ generation. Aβ found on ILVs could arise
from Aβ generation on the perimeter membrane of the MVB and
subsequent sorting onto ILVs, or γ-cleavage could occur on ILVs as
well as on the perimeter membrane. The previous immunoelectron
microscopy findings showing that Aβ42 in neurons normally
localizes preferentially to the MVB limiting membranes is
consistent with Aβ generation on the MVB perimeter membrane
(Takahashi et al., 2002). Intracellular Aβ levels depend on the
Fig. 5. Reduced lysosomal delivery after Hrs/Tsg101 depletion.
(A) H4-APP cells depleted of Hrs (siHrs) or Tsg101 (siTsg101) were
treated with or without leupeptin and stained with 6E10 (green) and
LAMP1 (red). Scale bars: 5 μm. (B) Quantification of 6E10
colocalization with LAMP1 (using Velocity). Results are mean±s.d. of
three experiments. *P<0.05, ***P<0.005 (Student’s t-test). (C) Fold
change (mean±s.d., n=2 separate experiments) of 6E10 colocalized
with LAMP1.
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balance between Aβ generation and Aβ degradation and secretion.
Hrs or Tsg101 depletion might increase Aβ levels by inhibiting
lysosomal delivery of APP or β-CTF, increasing the time that they
reside in MVBs, but also increasing Aβ accumulation through
reduced Aβ secretion.
What is the role of Hrs and Tsg101 in Aβ secretion? Although the
major fate ofESCRT-dependent ILVs is degradation in the lysosome,
Aβ accumulation in MVBs could affect that fate. Consistently, a
defect in EGFR degradation has been observed upon Aβ
accumulation within MVBs (Almeida et al., 2006). One alternative
MVB fate is fusion with the cell surface and release of ILVs as
exosomes, and exosome-associated Aβ has been found (Rajendran
et al., 2006). Interestingly, one exosome population has been shown
to be generated independently of ESCRTs (Trajkovic et al., 2008),
but depletion of Hrs and Tsg101 has recently been shown to reduce
some exosome production (Colombo et al., 2013; Tamai et al., 2012,
2010), and ubiquitylated proteins have been found in exosomes
(Buschow et al., 2005). Thus, reduced exosome secretion could
contribute to the reduced Aβ secretion upon depletion of Hrs or
Tsg101. Additionally, non-exosome-associated Aβwithin the MVB
lumen could be released upon MVB fusion with the plasma
membrane and Hrs or Tsg101 could play a role in this fusion.
Another possible fate of MVBs is fusion with autophagosomes in a
process that participates in autophagic degradation (Lamb et al.,
2013). The accumulation of autophagic vacuoles in Alzheimer’s
disease brain (Nixon et al., 2005) and mouse Alzheimer’s disease
models (Yu et al., 2005) suggests a link between Aβ accumulation
and autophagy. ESCRT proteins are required for efficient autophagic
degradation (Rusten and Simonsen, 2008), but, in an intriguing
recent development, genetic ablation of autophagy by knockout of
Atg7 has been shown to dramatically reduce Aβ secretion (Nilsson
et al., 2013; Nilsson and Saido, 2014). Clearly the relationship
between ESCRT-mediated sorting of APPonto ILVs, autophagy and
Aβ secretion is a major subject for future study.
Fig. 6. Reduced Aβ40 secretion and increased intracellular
APP and/or Aβ after depletion of Hrs or Tsg101. (A) ELISA
shows reduced Aβ40 secretion in N2a-APP cells depleted of of
Hrs (siHrs) or Tsg101 (siTsg101). (B) Hrs or Tsg101 depletion
does not affect release of LDH activity into culture medium.
(C–G) N2a-APP cells were depleted of Hrs or Tsg101 andmedia
(C,D) and cell lysates (E–G) were analysed by western blotting.
All results are mean±s.d. of three experiments. *P<0.05,
***P<0.005 (Student’s t-test).
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Understanding themolecularmechanisms that regulate intracellular
Aβ accumulation is crucial to understanding early Alzheimer’s
disease pathogenesis. Increasing evidence indicates that intracellular
Aβ accumulation in Alzheimer’s-disease-vulnerable neurons initiates
synaptic dysfunction prior to the presence of amyloid plaques. Our
data indicate a key role for early ESCRT components in limiting
intracellular Aβ accumulation by sortingAPP onto ILVs ofMVBs for
lysosomal degradation and promoting Aβ secretion.
MATERIALS AND METHODS
Reagents
Anti-APP/Aβ antibodies were mouse 6E10 and 4G8, against residues 3–8 and
17–24 of Aβ respectively (Covance), rabbit 369 against CTF (Buxbaum et al.,
1990), and mouse G2-10 (Aβ40-specific) and P2-1 (N-terminus) (Millipore).
Sheep anti-TGN46 (AbDSerotec), rabbit anti-CathepsinD (Upstate), -LAMP1
(Ab24170 - Abcam), -Myc (Abcam), and mouse anti-Hrs (Enzo Lifesciences)
and Tsg101 (Genetex) antibodies were used. Leupeptin and cycloheximide
(Sigma) were used at 50 μg/ml and 40 μg/ml, respectively.
Cell culture
Human H4 neuroglioma cells (H4) cells from ATCC were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal calf serum
(FCS). N2a mouse neuroblastoma cells (generously provided by Gopal
Thinakaran and Sangram Sisodia – University of Chicago) were cultured in
47.5% DMEM, 47.5% OptiMem and 5% FCS, with 0.4 mg/ml Geneticin
(Invitrogen).
Western blotting
Western blotting to analyse knockdown efficiencies were performed as
previously described (Edgar et al., 2014). To perform western blotting for
Aβ, medium was collected and cells were harvested in ice-cold PBS. Cell
pellets were lysed in 6% SDS, 1% β-mercaptoethanol, sonicated and
heated at 95°C. Centrifuged (10,600 g for 10 min) supernatants were
electrophoresed, transferred to PVDF membranes (Millipore), and boiled in
PBS. Blocking and antibody incubations were in 0.1% Tween-20 (PBST)
with 5% milk powder. Immunoreactions were visualized by
chemiluminescence (Pierce) and quantified with Image Lab (Bio-Rad).
Co-immunoprecipitation
The ubiquitin–Myc construct was a kind gift fromSylvieUrbe (University of
Liverpool, UK). Cells were scraped in lysis buffer containing 10 mM NEM
and lysates incubatedwith 10 μg of primary antibody for 4 h and then protein
G beads (Santa Cruz Biotechnology) for 1 h. Washed pellets were boiled in
reducing sample buffer and analysed by SDS-PAGE and western blotting.
RNA interference
Cells were transfected using Oligofectamine (Invitrogen) with 20 μM
negative control siRNA (Mammalian AllStar negative siRNA), or human
Hrs or Tsg101 (Razi and Futter, 2006), murine Hrs ON-TARGETplus
SMARTpool siRNA or murine Tsg101 ON-TARGETplus SMARTpool
siRNA sequences (Quiagen).
Cryo-immunoelectron microscopy
Cultured cells were prepared and sectioned as described (Edgar et al., 2014).
For mouse brains, 10-month-old mice expressing human-sweAPP (Tg2576
mice; Hsiao et al., 1996) and wild-type littermates were perfusion fixed with
4% PFA. 50-μm vibratome sections of hippocampus were dissected and
embedded in 12% gelatin before preparation as above. Sections were
immunogold labelled (Slot et al., 1991) and visualized with a JEOL1010
transmission electron microscope with a Gatan digital camera and Digital
Micrograph software. All animal experiments were approved by the Animal
Ethical Committee of Lund University (Sweden).
Immunofluorescence
Cells were fixed with 4% PFA, permeabilized with 0.1% saponin, and then
blocking, antibody incubations and washes were in 1% BSA and 0.01%
saponin in PBS. Coverslips were mounted in DAPI-containing medium
Prolong gold anti-fade reagent (Invitrogen). For EGF-trafficking
experiments, cells were serum starved for 90 min before incubation with
200 ng/ml EGF–Alexa-Fluor-488 (Molecular Probes).Cells were visualized
using a Leica TCS SP2 AOBS confocal microscope using a 63× oil
immersion lens. Images were analysed using Methamorph Image Analysis
or Velocity software.
Human Aβ40 ELISA
HumanAβ40 secreted over 48 h was measured in culture medium by ELISA
(Invitrogen).
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J. Cell Sci. 128: doi:10.1242/jcs.170233: Supplementary Material 
Supplementary Figure 1 – Inhibition of y-secretease does not alter 6E10, and the N-
terminus of APP displays the same localization at 6E10. (A) H4-APP cells were treated with 
the y-secretase inhibitor DAPT (1 ng/ml, 18 hours) before being fixed and analysed by 
immunofluorescence.  Cells were stained with the anti-APP/Aβ antibody 6E10 (green) and an 
anti-TGN46 antibody (magenta). Scale bar 10µm.   (B) Cells were similarly treated with DAPT 
and processed for cryosectioning.  Thawed cryosections were stained with the anti-APP/Aβ 
antibody 6E10.  Scale bar 200nm.  (C) H4-APP or untransfected cells were fixed and stained with 
the N-terminal APP antibody, P2-1 (green) and imaged by confocal microscopy.  Scale bar 10µm. 
(D) H4-APP cells were fixed and prepared for cryosectioning.  Ultrathin cryosections were 
stained using the anti-N-terminal APP antibody, P2-1.  Scale bars 100nm. 
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Supplementary Figure 2 – APP undergoes ubiquitination. (A) N2a-UnT and N2a-APP cells 
transfected with a myc-tagged ubiquitin construct were lysed and immunoprecipitated using anti-
APP/Aβ antibody, 6E10.  Pull-downs were Western blotted with anti-myc antibody. (B) 
Schematic of potential sites of ubiquitination within APP. 
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Supplementary Figure 3 - N2a-APP cells display similar morphology to H4-APP cells 
following siHrs or siTsg101 depletion.  N2a-APP cells were depleted for Hrs or Tsg101 and 
stained for APP (green) and LAMP1 (red).  Scale bar 10µm. 
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